PTGX Dividend History & Analysis | N/A Yield
PTGX has a dividend yield of N/A and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.
Top Dividend Payers in Biotechnology
| Symbol | Market Cap USD | Dividend Yield TTM | Yield on Cost 5y |
|---|---|---|---|
| ABBV | 390,557 M | 3.34% | 7.41% |
| AMGN | 183,880 M | 3.21% | 5.96% |
| GILD | 176,133 M | 2.79% | 5.59% |
| HLN | 46,623 M | 1.76% | 2.46% |
| REGN | 80,328 M | 0.54% | 0.71% |
| Symbol | Market Cap USD | Growth Rate | Consistency |
|---|---|---|---|
| BTX | 1,425 M | 134% | 95.6% |
| HLN | 46,623 M | 30.1% | 100% |
| AMGN | 183,880 M | 7.84% | 100% |
| BIM | 13,688 M | 9.76% | 96.0% |
| ABBV | 390,557 M | 5.98% | 100% |
Quality Dividend Peers in Biotechnology
3.21% Yield
2.79% Yield
PTGX Dividend History: as of February 2026
No dividends paid yet.PTGX Dividend FAQ
Protagonist Therapeutics (NASDAQ: PTGX) is a U.S. biotech focused on peptide-based drugs for hematologic, inflammatory, and immunomodulatory indications. Its lead assets include Rusfertide, a hepcidin-mimetic in Phase 3 for polycythemia vera; Icotrokinra, an oral small-molecule designed to block pathways currently targeted by injectable antibodies, also in Phase 3; and PN-943, an oral gut-restricted α4β7 integrin antagonist that completed a Phase 2 trial in moderate-to-severe ulcerative colitis. Early-stage programs comprise an oral IL-17 antagonist (PN-88), an oral metabolic/obesity peptide, and a pre-clinical oral hepcidin mimetic/ferroportin blocker.
What is the Dividend Yield of PTGX?
As of February 2026, PTGX`s dividend yield is %. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 85.59.Does PTGX pay a dividend?
As of February 2026 PTGX does not pay a dividend.How often does PTGX pay dividends?
Over the last 12 months, PTGX has issued dividend payments.PTGX dividend forecast
Based on historical data, the forecasted dividends per share for PTGX for the next 4 payments are between 0 (+0.0%) and 0 (+0.0%).This suggests the dividend will remain relatively stable.
Will PTGX pay dividends in 2026?
The next Ex-Dividend date for Protagonist Therapeutics (PTGX) is currently unknown.What is the next Ex-Dividend Date for PTGX?
The next Ex-Dividend date for Protagonist Therapeutics (PTGX) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.What is the Dividend Growth of PTGX?
PTGX's average dividend growth rate over the past 5 years is -% per year.
What is the Yield on Cost of PTGX?
PTGX's 5-Year Yield on Cost is -%. If you bought PTGX's shares at 22.38 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.What is the Payout Consistency of PTGX?
PTGX Payout Consistency is 0.0%.
The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.
Does PTGX have a good Dividend Yield?
PTGX`s % Dividend Yield is considered as unknown.What is the Dividend Payout Ratio of PTGX?
The Dividend Payout Ratio of PTGX is unknown.What is the Dividend Rating of PTGX?
PTGX`s Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.Key Metric Definitions
- Dividend Yield
- Annual dividend per share divided by current share price.
- Payout Ratio
- Percentage of earnings paid as dividends. Below 60% = safe, above 100% = unsustainable.
- Payout FCF
- Percentage of Free Cash Flow paid as dividends. More reliable than Payout Ratio since it measures actual cash.
- Growth Rate (CAGR)
- Compound annual growth rate of dividends over the last 5 years.
- Consistency
- Reliability of dividend payments over lifetime. Penalizes cuts and pauses.
- Yield on Cost
- Your effective yield if you bought 5 years ago. Shows dividend growth impact over time.
- Streak
- Consecutive years of dividend payments. 25+ years = Dividend Aristocrat.
- Dividend Rating
- Proprietary score (0-100) combining yield, growth, safety and consistency.
Last update: 2026-02-02 02:16